BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20334669)

  • 1. Influence of production process design on inclusion bodies protein: the case of an Antarctic flavohemoglobin.
    Parrilli E; Giuliani M; Marino G; Tutino ML
    Microb Cell Fact; 2010 Mar; 9():19. PubMed ID: 20334669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant production of ESAT-6 antigen in thermoinducible Escherichia coli: the role of culture scale and temperature on metabolic response, expression of chaperones, and architecture of inclusion bodies.
    Restrepo-Pineda S; Bando-Campos CG; Valdez-Cruz NA; Trujillo-Roldán MA
    Cell Stress Chaperones; 2019 Jul; 24(4):777-792. PubMed ID: 31165436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New properties of inclusion bodies with implications for biotechnology.
    Peternel S; Jevsevar S; Bele M; Gaberc-Porekar V; Menart V
    Biotechnol Appl Biochem; 2008 Apr; 49(Pt 4):239-46. PubMed ID: 17708747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma.
    Krachmarova E; Ivanov I; Nacheva G
    Microb Cell Fact; 2020 Jul; 19(1):139. PubMed ID: 32652996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality comparison of recombinant soluble proteins and proteins solubilized from bacterial inclusion bodies.
    López-Cano A; Sicilia P; Gaja C; Arís A; Garcia-Fruitós E
    N Biotechnol; 2022 Dec; 72():58-63. PubMed ID: 36150649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of membrane beta-barrel protein in E. coli at low temperatures: Structure of Yersinia pseudotuberculosis OmpF porin inclusion bodies.
    Solov'eva TF; Bakholdina SI; Khomenko VA; Sidorin EV; Kim NY; Novikova OD; Shnyrov VL; Stenkova AM; Eremeev VI; Bystritskaya EP; Isaeva MP
    Biochim Biophys Acta Biomembr; 2022 Sep; 1864(9):183971. PubMed ID: 35643329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
    Panda AK
    Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pre-induction temperature affects recombinant HuGM-CSF aggregation in thermoinducible Escherichia coli.
    Restrepo-Pineda S; Sánchez-Puig N; Pérez NO; García-Hernández E; Valdez-Cruz NA; Trujillo-Roldán MA
    Appl Microbiol Biotechnol; 2022 Apr; 106(8):2883-2902. PubMed ID: 35412129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality control of inclusion bodies in Escherichia coli.
    Jürgen B; Breitenstein A; Urlacher V; Büttner K; Lin H; Hecker M; Schweder T; Neubauer P
    Microb Cell Fact; 2010 May; 9():41. PubMed ID: 20509924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant protein production in Antarctic Gram-negative bacteria.
    Duilio A; Tutino ML; Marino G
    Methods Mol Biol; 2004; 267():225-37. PubMed ID: 15269427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teaching an old pET new tricks: tuning of inclusion body formation and properties by a mixed feed system in E. coli.
    Wurm DJ; Quehenberger J; Mildner J; Eggenreich B; Slouka C; Schwaighofer A; Wieland K; Lendl B; Rajamanickam V; Herwig C; Spadiut O
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):667-676. PubMed ID: 29159587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human growth hormone inclusion bodies present native-like secondary and tertiary structures which can be preserved by mild solubilization for refolding.
    Chura-Chambi RM; Farah CS; Morganti L
    Microb Cell Fact; 2022 Aug; 21(1):164. PubMed ID: 35978337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of functional inclusion bodies in endotoxin-free Escherichia coli.
    Rueda F; Cano-Garrido O; Mamat U; Wilke K; Seras-Franzoso J; García-Fruitós E; Villaverde A
    Appl Microbiol Biotechnol; 2014 Nov; 98(22):9229-38. PubMed ID: 25129611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant production of a single-chain antibody fragment in Pseudoalteromonas haloplanktis TAC125.
    Giuliani M; Parrilli E; Sannino F; Apuzzo GA; Marino G; Tutino ML
    Appl Microbiol Biotechnol; 2014 Jun; 98(11):4887-95. PubMed ID: 24535258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active protein aggregates produced in Escherichia coli.
    Peternel S; Komel R
    Int J Mol Sci; 2011; 12(11):8275-87. PubMed ID: 22174663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives of inclusion bodies for bio-based products: curse or blessing?
    Slouka C; Kopp J; Spadiut O; Herwig C
    Appl Microbiol Biotechnol; 2019 Feb; 103(3):1143-1153. PubMed ID: 30569219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermoinducible E. coli for Recombinant Protein Production in Inclusion Bodies.
    Valdez-Cruz NA; Trujillo-Roldán MA
    Methods Mol Biol; 2023; 2617():17-30. PubMed ID: 36656514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactiplantibacillus plantarum: a new example of inclusion body producing bacteria.
    Baltà-Foix R; Serrano-Adrover C; López-Cano A; Gifre-Renom L; Sanchez-Chardi A; Arís A; Garcia-Fruitós E
    Microb Cell Fact; 2023 Jun; 22(1):111. PubMed ID: 37296442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Custom made inclusion bodies: impact of classical process parameters and physiological parameters on inclusion body quality attributes.
    Slouka C; Kopp J; Hutwimmer S; Strahammer M; Strohmer D; Eitenberger E; Schwaighofer A; Herwig C
    Microb Cell Fact; 2018 Sep; 17(1):148. PubMed ID: 30236107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of Active Recombinant Hyaluronidase Inclusion Bodies from
    Schwaighofer A; Ablasser S; Lux L; Kopp J; Herwig C; Spadiut O; Lendl B; Slouka C
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.